NephJC #2 - Atrasentan: Analytics and Transcript
NephJC coverage is linked to PubMed
I fixed up the wikipedia article on atrasentan
The new journal club for Tuesday is a study of atrasentan for diabetic kidney disease. When I wrote introduction post I went to wikipedia and learned that atrasentan had been in trials as an antineoplastic agent. I went to the Twitter and asked if anyone was using it.
He then gave me the keys to the kingdom by showing me where to search NCI site for trials. Bingo.
I was Quickly able to find the failed phase 3 trial and updated wikipedia.
Central American CKD
Swapnil likes it
Clinical practice guideline for #NephJC?
What do people think about this? Is this appropriate for journal club or is this akin to doing a review article?
The #NephJC logo
Flattering coverage of the first NephJC
Kristina Fiore, friend of nephrology social media did a really nice post about NephJC.
Central American CKD Epidemic
May 13th is locked in for our next journal club
The article is chosen and we will reveal it next week. The article was submitted to us by multiple people via twitter, keep those suggestions coming. #NephJC
Tejas steps up...
Tejas Desai helpfully Storified the first NephJC discussion
The first live tweet chat is a wrap!
You can see the transcript or download the PDF (20 pages)
another one
possible article
Another possible article
Possible future article
Some posts about the first NephJC
Some information on how to participate with NephJC at PBFluids.com.
eAJKD published a short post on NephJC by Joel.
The Renal Fellow Network posted a nice introduction to the journal club by Paul Phellan.
Challenge Accepted!
Can we keep the momentum for #NephJC going after the first two Journal Clubs?
Medium
We posted at Medium before we had NephJC.com up and running. You can find these posts here:
Nephrology Journal Club on Twitter
The whats, whys and whens explained
NephJC 1: CKD Screening Works
Educational programs improve survival of patients with CKD